In the first trial with human subjects, it reduced the number of immune system 'killer' cells that attack crucial insulin-producing cells, study shows.
A
"reverse vaccine" that allows people with Type 1 diabetes to produce
their own insulin has passed its first test with human subjects,
according to a new study.
The success points to a potential new strategy for treating those in the early stages of the disease, experts said.
The therapy is designed to protect cells in the pancreas that make insulin, a hormone the body needs to convert sugars and starches into energy.
In people with Type 1 diabetes, the immune system goes haywire and attacks those crucial insulin-producing cells for reasons that medical researchers don't understand.
The success points to a potential new strategy for treating those in the early stages of the disease, experts said.
The therapy is designed to protect cells in the pancreas that make insulin, a hormone the body needs to convert sugars and starches into energy.
In people with Type 1 diabetes, the immune system goes haywire and attacks those crucial insulin-producing cells for reasons that medical researchers don't understand.
0 comments:
Post a Comment